
Designing for Access: Early Integrated Evidence Generation Planning
Impactful evidence starts with strategy, not data.
As regulatory, HTA and payer expectations rise, reactive evidence generation falls short. The shift to integrated evidence generation planning (IEGP) is critical to ensure evidence does more than fill gaps; it drives decisions.
In this webinar, discover ways to combine health economics, market access, patient-centered research and real-world data and evidence into a single, strategy-led approach that delivers decision-grade impact across the product lifecycle.
Focused on EU HTA, with global relevance, gain practical ways to navigate evolving demands around comparators, endpoints and uncertainty.
You’ll learn how to:
- Proactively identify and close evidence gaps.
- Align endpoints, comparators and economic models with payer and HTA expectations.
- Strengthen clinical evidence with patient-centered data.
- Use real world evidence (RWE) to reduce uncertainty and accelerate decisions.
Turn strategy into proof and evidence into action to drive regulatory confidence, HTA outcomes and payer value.
Presenters

Pedro Saramago Goncalves
MSc, PhD, research scientist, consulting, PPD Evidera health economics and market access, Thermo Fisher Scientific

Daniel Bretton
BSc, senior consultant, PPD Evidera health economics and market access, Thermo Fisher Scientific

Sebastian Heidenreich
PhD, executive director, PPD Evidera patient-centered research, Thermo Fisher Scientific

Mark Yates
MBChB (MD), PhD, director of RWE strategy and RWD solutions, PPD Evidera real world data & scientific solutions, Thermo Fisher Scientific
